glp-1 drugs for weight loss Understanding pills: A new alternative to injections Amazon.com: GLP-1 Weight Loss -

If confidence in this approach depends on the belief that it has already been studied at scale, that belief is not supported by current evidence

34% of patients) or HFpEF to dapagliflozin or placebo

Research news A University of Texas at El Paso study has found that people with type 2 diabetes or obesity who used glucagon-like peptide-1 receptor agonists had lower odds of alcohol, opioid, nicotine and cocaine use disorders, although researchers said clinical trials were needed before the drugs could be considered for addiction treatment A study led by researchers at The University of Texas at El Paso, USA, has found that the use of diabetes and weight loss medicines such as Ozempic was associated with a lower risk of alcohol, opioid, nicotine and cocaine use disorders

Clinical trials demonstrate that higher doses generally produce greater weight reduction, but individual responses vary considerably

[DOI] [PMC free article] [PubMed] [Google Scholar] 74.Hropot T, Herman R, Janez A, Lezaic L, Jensterle M